Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review KA Phillips, DL Veenstra, E Oren, JK Lee, W Sadee Jama 286 (18), 2270-2279, 2001 | 992 | 2001 |
Strategies and methods for research on sex differences in brain and behavior JB Becker, AP Arnold, KJ Berkley, JD Blaustein, LA Eckel, E Hampson, ... Endocrinology 146 (4), 1650-1673, 2005 | 942 | 2005 |
ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma NY Frank, A Margaryan, Y Huang, T Schatton, AM Waaga-Gasser, ... Cancer research 65 (10), 4320-4333, 2005 | 762 | 2005 |
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing KA Birdwell, B Decker, JM Barbarino, JF Peterson, CM Stein, W Sadee, ... Clinical Pharmacology & Therapeutics 98 (1), 19-24, 2015 | 717 | 2015 |
Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C> T affects mRNA stability D Wang, AD Johnson, AC Papp, DL Kroetz, W Sadee Pharmacogenetics and genomics 15 (10), 693-704, 2005 | 646 | 2005 |
Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G Y Zhang, D Wang, AD Johnson, AC Papp, W Sadée Journal of Biological Chemistry 280 (38), 32618-32624, 2005 | 637 | 2005 |
Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs D Wang, Y Guo, SA Wrighton, GE Cooke, W Sadee The pharmacogenomics journal 11 (4), 274-286, 2011 | 611 | 2011 |
Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory Y Zhang, A Bertolino, L Fazio, G Blasi, A Rampino, R Romano, MLT Lee, ... Proceedings of the National Academy of Sciences 104 (51), 20552-20557, 2007 | 509 | 2007 |
MicroRNAs modulate the chemosensitivity of tumor cells PE Blower, JH Chung, JS Verducci, S Lin, JK Park, Z Dai, CG Liu, ... Molecular cancer therapeutics 7 (1), 1-9, 2008 | 449 | 2008 |
5′-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter H Han, RLA De Vrueh, JK Rhie, KMY Covitz, PL Smith, CP Lee, DM Oh, ... Pharmaceutical research 15, 1154-1159, 1998 | 428 | 1998 |
Innate immune gene polymorphisms in tuberculosis AK Azad, W Sadee, LS Schlesinger Infection and immunity 80 (10), 3343-3359, 2012 | 401 | 2012 |
Phosphorylation and agonist‐specific intracellular trafficking of an epitope‐tagged μ‐opioid receptor expressed in HEK 293 cells JR Arden, V Segredo, Z Wang, J Lameh, W Sadée Journal of neurochemistry 65 (4), 1636-1645, 1995 | 383 | 1995 |
Cystine-Glutamate Transporter SLC7A11 in Cancer Chemosensitivity and Chemoresistance Y Huang, Z Dai, C Barbacioru, W Sadée Cancer research 65 (16), 7446-7454, 2005 | 366 | 2005 |
Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance Y Huang, P Anderle, KJ Bussey, C Barbacioru, U Shankavaram, Z Dai, ... Cancer research 64 (12), 4294-4301, 2004 | 366 | 2004 |
Pharmacogenomics: the promise of personalized medicine L Mancinelli, M Cronin, W Sadée Aaps Pharmsci 2, 29-41, 2000 | 359 | 2000 |
Pharmacogenetics/genomics and personalized medicine W Sadee, Z Dai Human molecular genetics 14 (suppl_2), R207-R214, 2005 | 326 | 2005 |
Membrane transporters and channels in chemoresistance and-sensitivity of tumor cells Y Huang, W Sadée Cancer letters 239 (2), 168-182, 2006 | 324 | 2006 |
MicroRNA expression profiles for the NCI-60 cancer cell panel PE Blower, JS Verducci, S Lin, J Zhou, JH Chung, Z Dai, CG Liu, ... Molecular cancer therapeutics 6 (5), 1483-1491, 2007 | 310 | 2007 |
The Venus flytrap of periplasmic binding proteins: an ancient protein module present in multiple drug receptors CB Felder, RC Graul, AY Lee, HP Merkle, W Sadee AAps pharmsci 1, 7-26, 1999 | 303 | 1999 |
Hydrophobic amino acid in the i2 loop plays a key role in receptor-G protein coupling. O Moro, J Lameh, P Högger, W Sadee Journal of Biological Chemistry 268 (30), 22273-22276, 1993 | 270 | 1993 |